I think an 80% effectiveness rate is a fair bit higher than you get from using bednets—if I recall correctly they tend to reduce malaria deaths (or perhaps cases) by 30-50%.
The question is cost-effectiveness. If it’s a few dollars for the whole set of vaccines (‘three initial doses followed by a booster a year later’), and this includes distribution costs, then this seems pretty clearly more cost-effective than bednets.
I think an 80% effectiveness rate is a fair bit higher than you get from using bednets—if I recall correctly they tend to reduce malaria deaths (or perhaps cases) by 30-50%.
The question is cost-effectiveness. If it’s a few dollars for the whole set of vaccines (‘three initial doses followed by a booster a year later’), and this includes distribution costs, then this seems pretty clearly more cost-effective than bednets.